Abstract:In the colorectal cancer (CRC) niche, the transcription factors signal transducer and activator of transcription 3 (STAT3) and nuclear factor-κB (NF-κB) are hyperactivated in both malignant cells and tumor-infiltrating leukocytes (TILs) and cooperate to maintain cancer cell proliferation/survival and drive protumor inflammation. Through drug repositioning studies, the anthelmintic drug rafoxanide has recently emerged as a potent and selective antitumor molecule for different types of cancer, including CRC. Here, we investigate whether rafoxanide could negatively modulate STAT3/NF-κB and inflammation-associated CRC. The antineoplastic effect of rafoxanide was explored in a murine model of CRC resembling colitis-associated disease. Cell proliferation and/or STAT3/NF-κB activation were evaluated in colon tissues taken from mice with colitis-associated CRC, human CRC cells, and CRC patient-derived explants and organoids after treatment with rafoxanide. The STAT3/NF-κB activation and cytokine production/secretion were assessed in TILs isolated from CRC specimens and treated with rafoxanide. Finally, we investigated the effects of TIL-derived supernatants cultured with or without rafoxanide on CRC cell proliferation and STAT3/NF-κB activation. The results showed that rafoxanide restrains STAT3/NF-κB activation and inflammation-associated colon tumorigenesis in vivo without apparent effects on normal intestinal cells. Rafoxanide markedly reduces STAT3/NF-κB activation in cultured CRC cells, CRC-derived explants/organoids, and TILs. Finally, rafoxanide treatment impairs the ability of TILs to produce protumor cytokines and promote CRC cell proliferation. We report the novel observation that rafoxanide negatively affects STAT3/NF-κB oncogenic activity at multiple levels in the CRC microenvironment. Our data suggest that rafoxanide could potentially be deployed as an anticancer drug in inflammation-associated CRC.

Rafoxanide Promotes Apoptosis and Autophagy of Gastric Cancer Cells by Suppressing PI3K /akt/mtor Pathway

Rafoxanide, an Organohalogen Drug, Triggers Apoptosis and Cell Cycle Arrest in Multiple Myeloma by Enhancing DNA Damage Responses and Suppressing the P38 MAPK Pathway

Antitumor Effects of Rafoxanide in Diffuse Large B Cell Lymphoma Via the PTEN/PI3K/Akt and JNK/c-Jun Pathways.

Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis

Efficacy of Rigosertib, a Small Molecular RAS Signaling Disrupter for the Treatment of KRAS-mutant Colorectal Cancer

Rauwolfia Vomitoria Extract Represses Colorectal Cancer Cell Autophagy and Promotes Apoptosis

Rigosertib Promotes Anti-Tumor Immunity Via Autophagic Degradation of PD-L1 in Colorectal Cancer Cells

Irinotecan Induces Autophagy-Dependent Apoptosis and Positively Regulates ROS-Related JNK- and P38-MAPK Pathways in Gastric Cancer Cells

ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin

The VEGFR2/mTOR/S6K1 pathway involved in the angiogenic effects of roxarsone in vitro and in vivo

Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells Via the Pi3k/Akt/Mtor Pathway

Knockdown of Rap1b Enhances Apoptosis and Autophagy in Gastric Cancer Cells via the PI3K/Akt/mTOR Pathway.

Autophagy plays a protective role against apoptosis induced by toxicarioside N via the Akt/mTOR pathway in human gastric cancer SGC-7901 cells

Celecoxib Regulates Apoptosis And Autophagy Via The Pi3k/Akt Signaling Pathway In Sgc-7901 Gastric Cancer Cells

Synergistic Antitumor Activity of Rapamycin and EF24 Via Increasing ROS for the Treatment of Gastric Cancer.

A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo

Mitochondrial ROS Accumulation Inhibiting JAK2/STAT3 Pathway is a Critical Modulator of CYT997-induced Autophagy and Apoptosis in Gastric Cancer

Inhibition of RhoA/ROCK Signaling Pathway Promotes the Apoptosis of Gastric Cancer Cells.

ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer.

Natriuretic Peptide Receptor A Inhibition Suppresses Gastric Cancer Development Through Reactive Oxygen Species-Mediated G2/M Cell Cycle Arrest and Cell Death.

Ginsenoside Rg5 Induces G2/M Phase Arrest, Apoptosis and Autophagy Via Regulating ROS-mediated MAPK Pathways Against Human Gastric Cancer.